Advancing Pharmaceutical Production: The Benefits of Flow Manufacturing for Nanomedicines

Nanomedicines demand tight control over particle properties, reproducibility, and scalability, yet conventional batch methods often struggle to deliver all three.

In this whitepaper, Ardena’s nanomedicines experts Mark van Eldijk and Andy Bänzinger explore how flow manufacturing can enable more consistent nanoparticle production, simplify scale-up, and support robust development pathways from early-stage research through GMP manufacturing.

The paper includes a practical case study using a multi-inlet vortex mixer (MIVM) for liposome production, showing how key process parameters influence particle size and polydispersity.

Download the whitepaper to learn:

Why flow manufacturing improves reproducibility compared to batch processes
How continuous processing supports scalable nanoparticle production
A real formulation case study demonstrating parameter-driven control

Get the whitepaper by filling in the form.

Interested in reading the full resource?

Please fill out the form to unlock the rest of the content.

Payloads and API

Building Blocks

Nanomedicine Development

Nanomedicine Manufacturing

Fill & Finish and Clinical Supply

Regulatory and Bioanalysis

Lipid-based Nanoparticles

Polymeric Nanoparticles

Metal Nanoparticles

Our experience

Our integrated services

Our infrastructure

About Ardena Nanomedicines

Our nanomedicine facility

Working at Ardena Nanomedicines

Advancing Pharmaceutical Production: The Benefits of Flow Manufacturing for Nanomedicines

Interested in reading the full resource?

Latest Resources

ADC & XDC Development, from Chemistry to Clinic

On-Demand Webinar: Nanomedicine Development from Lab to Clinic: Strategies to Overcome Scale-Up and Analytical Challenges

Evolution of Stability Guidelines: From the ICH Q1A-F Series to the Consolidated ICH Q1 Guideline

Nitrosamine Risk Assessment According to ICH M7

Deciphering the Complex Characteristics of Nanomedicine

Late-Stage Development and Manufacturing of Novel Excipients for Precision Nanomedicines and Targeted Therapies

Innovations in API Manufacturing of Small Molecule Drugs

Microfluidization for Precision Nanoparticle Engineering

Leading the Way in Nanomedicine Solutions

On-demand webinar: Mastering Nanomedicines Characterization: Techniques for Determining Particle Size Distribution Based on Dynamic Light Scattering

Using Flow Technology in Nanoparticle Synthesis

Advancing oligonucleotide therapeutics with cutting-edge bioanalytics

Fit-for-Phase Nanomedicine Solutions

Deciphering the complex characteristics of nanoparticles by asymmetric flow field-flow fractionation

Navigating the CMC Regulatory Landscape for Oligonucleotide Therapeutics

Which solubility-enhancing technology should I use to support my early drug development project?

Want to hear more from Ardena?